about
Clinical and genetic spectrum in limb-girdle muscular dystrophy type 2EMuscle involvement in limb-girdle muscular dystrophy with GMPPB deficiency (LGMD2T).Exercise Therapy in Spinobulbar Muscular Atrophy and Other Neuromuscular Disorders.MRI as outcome measure in facioscapulohumeral muscular dystrophy: 1-year follow-up of 45 patients.Dysphagia is prevalent in patients with CPEO and single, large-scale deletions in mtDNA.A pilot study of muscle plasma protein changes after exercise.Fat Replacement of Paraspinal Muscles with Aging in Healthy Adults.Progression of cardiac involvement in patients with limb-girdle type 2 and Becker muscular dystrophies: A 9-year follow-up studyEndocrine function over time in patients with myotonic dystrophy type 1Muscle contractility in spinobulbar muscular atrophyNatural history of limb girdle muscular dystrophy R9 over 6 years: searching for trial endpoints.Aerobic training and postexercise protein in facioscapulohumeral muscular dystrophy: RCT studyMuscle biopsies off-set normal cellular signaling in surrounding musculatureSevere paraspinal muscle involvement in facioscapulohumeral muscular dystrophyMuscle contractility of leg muscles in patients with mitochondrial myopathiesRefining the spinobulbar muscular atrophy phenotype by quantitative MRI and clinical assessmentsRelationship between muscle inflammation and fat replacement assessed by MRI in facioscapulohumeral muscular dystrophyDisease progression and outcome measures in spinobulbar muscular atrophyA quantitative method to assess muscle edema using short TI inversion recovery MRIMRI IN NEUROMUSCULAR DISEASES: AN EMERGING DIAGNOSTIC TOOL AND BIOMARKER FOR PROGNOSIS AND EFFICACY
P50
Q35582438-B79F4ECC-9E14-43E3-B464-891CF601191EQ37334305-E10145B3-C4A9-43AA-8AE5-2606CFEFB8FCQ38639343-B24901B1-BA7C-48C2-9073-1566FDF9483CQ48131113-2366A169-A72F-4FB1-A438-EDF024D887C0Q50120855-429C31F2-DBE1-4DA8-8A47-C2FC7F52FC65Q50953843-FA819C1E-4A9D-4CF3-A7CF-8EFC8BD7C3D7Q54394837-1B5897BB-20A7-403C-8709-40C08E60708BQ60772288-AA0BEA9F-F126-4817-AF09-6A24454D8449Q60772295-422DF429-D500-470E-9AF8-3ED3021114E5Q64082911-8D70813C-0419-42C5-9591-2BF85814CB8EQ64885267-F750CE89-EB7B-49CD-8A02-5353618C51FAQ85559721-693EBCA6-66FD-463A-8D2C-DDB2C3D4F85AQ86570340-78D6E060-D556-4239-BB08-A808C2F812B6Q87629192-BF8F74DB-274F-4556-AD66-E036B9971D30Q90288929-47ED6BAF-6EEB-41C1-8895-A4E1740A44BBQ90891889-6854B617-B5FE-42AF-9AE7-DADAF250A23FQ91695006-93377AA5-9B1D-4039-B79B-52FD5BF9AC1AQ91752304-3A7461C6-EE6F-4E88-9867-DAEEFB86136EQ94461775-26EC74C9-2672-4915-9DE2-EF3AE61EFE84Q96112363-40B81CC3-5342-4497-A729-54D30BF520CC
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Julia R Dahlqvist
@en
Julia R Dahlqvist
@nl
type
label
Julia R Dahlqvist
@en
Julia R Dahlqvist
@nl
prefLabel
Julia R Dahlqvist
@en
Julia R Dahlqvist
@nl
P31
P496
0000-0002-3149-1661